Calle Rubio Myriam, Miravitlles Marc, Soler Cataluña Juan José, López-Campos José Luis, Alcázar Navarrete Bernardino, Fuentes Ferrer Manuel E, Rodríguez Hermosa Juan Luis
Pulmonology Department, Department of Medicine, Hospital Clínico San Carlos, School of Medicine, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBER de Enfermedades Respiratorias (CIBERES), Universidad Complutense de Madrid, Madrid, Spain.
Pulmonology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
PLoS One. 2025 Jan 9;20(1):e0314299. doi: 10.1371/journal.pone.0314299. eCollection 2025.
This study aimed to evaluate clinical control in chronic obstructive pulmonary disease (COPD), the consequences in terms of treatment decisions, and their potentially associated factors during follow-up of patients in real-life clinical practice.
EPOCONSUL 2021 is a cross-sectional audit that evaluated the outpatient care provided to patients with a diagnosis of COPD in respiratory clinics in Spain and multivariable logistic regression models to assess the relationships between clinical control and clinical inertia.
4225 patients from 45 hospitals in Spain were audited. Clinical control was analyzed in 1804 (42.7%) patients who met all the Spanish COPD Guidelines (GesEPOC) criteria. 49.1% of patients were classified as uncontrolled, and 42.2% of patients disagreed with the level of control determined by their doctor, which was reported as good during the visit. There was therapeutic inertia (TI), in other words not making any change or taking any action in the treatment of COPD, in 68.4% of uncontrolled patients and no action was taken during the visit for 9.1% of uncontrolled patients. Factors associated with TI in uncontrolled patients were disagreement with the degree of control reported by the doctor who performed the examination ☯physician classifies and reports disease as controlled versus uncontrolled, OR: 3.37 (2.33-4.88), p<0.001] and having a lower burden of associated comorbidities ☯Charlson comorbidity index ≥3 versus <3, OR 0.8 (0.1-3.0), p = 0.014]. The probability of disagreeing with the physician's classification of the degree of COPD control in uncontrolled patients was lower in patients with severe exacerbations ☯OR 0.3 (0.17-0.78), p = 0.009] and those with more exacerbations in the last year ☯OR 0.6 (0.4-0.9), p = 0.019].
Therapeutic inertia exists in more than half of uncontrolled patients and is more likely when there is disagreement with the assessment of the physician responsible for the visit, who reported there being good disease control, a situation that was more likely in patients with less history of exacerbations.
本研究旨在评估慢性阻塞性肺疾病(COPD)患者在现实临床实践随访期间的临床控制情况、治疗决策的后果及其潜在相关因素。
EPOCONSUL 2021是一项横断面审计,评估了西班牙呼吸诊所为诊断为COPD的患者提供的门诊护理,并采用多变量逻辑回归模型评估临床控制与临床惰性之间的关系。
对西班牙45家医院的4225例患者进行了审计。对1804例(42.7%)符合所有西班牙COPD指南(GesEPOC)标准的患者进行了临床控制分析。49.1%的患者被归类为未得到控制,42.2%的患者不同意医生在就诊时判定的良好控制水平。在68.4%未得到控制的患者中存在治疗惰性,即对COPD治疗未做任何改变或采取任何行动,9.1%未得到控制的患者在就诊时未采取任何行动。未得到控制的患者中与治疗惰性相关的因素包括不同意进行检查的医生报告的控制程度[医生将疾病分类并报告为得到控制与未得到控制,比值比(OR):3.37(2.33 - 4.88),p<0.001]以及合并症负担较低[Charlson合并症指数≥3与<3,OR 0.8(0.1 - 3.0),p = 0.014]。在严重加重的患者[OR 0.3(0.17 - 0.78),p = 0.009]和过去一年中加重次数较多的患者[OR 0.6(0.4 - 0.9),p = 0.019]中,未得到控制的患者不同意医生对COPD控制程度分类的可能性较低。
超过一半未得到控制的患者存在治疗惰性,当与负责就诊的医生的评估存在分歧时更有可能出现这种情况,该医生报告疾病控制良好,这种情况在加重病史较少的患者中更常见。